Variant report

Variant	esv3514472
Chromosome Location	chr11:49306026-49363024
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr11:49332869-49333147	HepG2	liver:	n/a	n/a
2	CEBPB	chr11:49332880-49333223	IMR90	lung:	n/a	n/a
3	CTCF	chr11:49311960-49311967	Kidney_OC	kidney:	n/a	n/a
4	CTCF	chr11:49324010-49324181	HUVEC	blood vessel:	n/a	n/a
5	CTCF	chr11:49318017-49318064	Kidney_OC	kidney:	n/a	n/a
6	CTCF	chr11:49335020-49335089	ProgFib	skin:	n/a	n/a
7	CTCF	chr11:49339405-49339580	K562	blood:	n/a	n/a
8	CTCF	chr11:49324075-49324150	LNCaP	prostate:	n/a	n/a
9	CTCF	chr11:49340030-49340071	Pancreas_OC	pancreas:	n/a	n/a
10	CTCF	chr11:49324040-49324190	Caco-2	colon:	n/a	n/a
11	E2F4	chr11:49341977-49342137	MCF10A-Er-Src	breast:	n/a	n/a
12	E2F4	chr11:49360415-49360778	MCF10A-Er-Src	breast:	n/a	n/a
13	FOXA1	chr11:49306434-49306745	T-47D	breast:	n/a	chr11:49306617-49306629
14	FOXA1	chr11:49306436-49306788	T-47D	breast:	n/a	chr11:49306617-49306629
15	FOXA1	chr11:49308448-49308734	T-47D	breast:	n/a	chr11:49308600-49308615
16	JUN	chr11:49348960-49349482	HUVEC	blood vessel:	n/a	chr11:49349211-49349219 chr11:49349183-49349192
17	MAFF	chr11:49358901-49359089	K562	blood:	n/a	chr11:49358976-49358994
18	MAFF	chr11:49358837-49359104	HepG2	liver:	n/a	chr11:49358976-49358994
19	MAFK	chr11:49357196-49357396	HepG2	liver:	n/a	chr11:49357324-49357334 chr11:49357328-49357339 chr11:49357328-49357339
20	MAFK	chr11:49358808-49359111	HepG2	liver:	n/a	chr11:49358981-49358992
21	MAFK	chr11:49358878-49359087	HepG2	liver:	n/a	chr11:49358981-49358992
22	MAFK	chr11:49358896-49359082	Hela-S3	cervix:	n/a	chr11:49358981-49358992
23	MAFK	chr11:49341949-49342039	HepG2	liver:	n/a	n/a
24	MAFK	chr11:49358915-49359008	K562	blood:	n/a	chr11:49358981-49358992
25	MAFK	chr11:49337767-49337955	HepG2	liver:	n/a	chr11:49337897-49337908 chr11:49337895-49337909 chr11:49337896-49337912 chr11:49337896-49337907 chr11:49337897-49337908
26	MYC	chr11:49320036-49320151	MCF-7	breast:	n/a	n/a
27	MYC	chr11:49362411-49362611	MCF10A-Er-Src	breast:	n/a	n/a
28	POLR2A	chr11:49319079-49319102	K562	blood:	n/a	n/a
29	POLR2A	chr11:49354248-49354365	A549	lung:	n/a	n/a
30	POLR2A	chr11:49313748-49313930	MCF10A-Er-Src	breast:	n/a	n/a
31	POLR2A	chr11:49310275-49310475	MCF10A-Er-Src	breast:	n/a	n/a
32	POLR2A	chr11:49348698-49348754	HUVEC	blood vessel:	n/a	n/a
33	POLR2A	chr11:49320062-49320116	MCF-7	breast:	n/a	n/a
34	POLR2A	chr11:49329809-49329887	MCF10A-Er-Src	breast:	n/a	n/a
35	POLR2A	chr11:49314333-49314527	MCF10A-Er-Src	breast:	n/a	n/a
36	POLR2A	chr11:49340209-49340334	GM12878	blood:	n/a	n/a
37	POLR2A	chr11:49326609-49326749	ProgFib	skin:	n/a	n/a
38	POLR2A	chr11:49336353-49336511	MCF10A-Er-Src	breast:	n/a	n/a
39	POLR2A	chr11:49339879-49339997	GM12878	blood:	n/a	n/a
40	POLR2A	chr11:49306433-49306596	MCF10A-Er-Src	breast:	n/a	n/a
41	POLR2A	chr11:49319998-49320126	A549	lung:	n/a	n/a
42	POLR2A	chr11:49320173-49320263	MCF-7	breast:	n/a	n/a
43	POLR2A	chr11:49315646-49315687	MCF10A-Er-Src	breast:	n/a	n/a
44	POLR2A	chr11:49317762-49317923	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr11:49307325-49307607	SK-N-MC	brain:	n/a	n/a
46	POLR2A	chr11:49348466-49348595	HUVEC	blood vessel:	n/a	n/a
47	POLR2A	chr11:49320248-49320278	A549	lung:	n/a	n/a
48	POLR2A	chr11:49320614-49320795	GM12878	blood:	n/a	n/a
49	POLR2A	chr11:49341687-49341822	GM12878	blood:	n/a	n/a
50	POLR2A	chr11:49353520-49353659	MCF10A-Er-Src	breast:	n/a	n/a

Variant related genes	Relation type
ENSG00000255532	TF binding region

Extended variants
information (count: 827 )
Associated
traits (count: 46 )

Variant overlapped rSNPs/rCNVs (count:827 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12789191	chr11:49306033-49306034	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs555917527	chr11:49306036-49306037	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs56360955	chr11:49306043-49306044	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs181138581	chr11:49306051-49306052	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs376420930	chr11:49306052-49306053	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs12806285	chr11:49306063-49306064	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs184059977	chr11:49306084-49306085	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs188850547	chr11:49306085-49306086	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs140033455	chr11:49306086-49306087	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs143468054	chr11:49306093-49306094	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs535502779	chr11:49306141-49306142	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs548816395	chr11:49306188-49306189	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs565626283	chr11:49306211-49306212	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs367624820	chr11:49306246-49306247	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs181649098	chr11:49306251-49306252	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs557620282	chr11:49306252-49306253	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs112702234	chr11:49306307-49306308	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs1164682	chr11:49306361-49306362	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs556708978	chr11:49306386-49306387	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs573768845	chr11:49306396-49306397	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs373788916	chr11:49306434-49306435	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs186215253	chr11:49306441-49306442	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs541111856	chr11:49306442-49306443	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs572395712	chr11:49306454-49306455	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs17555964	chr11:49306508-49306509	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs192117928	chr11:49306558-49306559	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs114795756	chr11:49306563-49306564	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs201397331	chr11:49306585-49306586	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs544145612	chr11:49306617-49306618	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs7937756	chr11:49306643-49306644	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs529470328	chr11:49306645-49306646	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs372158892	chr11:49306647-49306648	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs549057685	chr11:49306663-49306664	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs565335488	chr11:49306726-49306727	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs578155908	chr11:49306732-49306733	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs528071765	chr11:49306770-49306771	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs149697759	chr11:49306785-49306786	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs182432603	chr11:49306786-49306787	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs147761997	chr11:49306791-49306792	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs10839254	chr11:49306795-49306796	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs536147811	chr11:49306804-49306805	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs556845799	chr11:49306822-49306823	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs567407548	chr11:49306850-49306851	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs536098442	chr11:49306854-49306855	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs555816733	chr11:49306855-49306856	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs185823178	chr11:49306887-49306888	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs191115902	chr11:49306903-49306904	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs558152044	chr11:49306969-49306970	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs375069083	chr11:49307064-49307065	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs374718726	chr11:49307101-49307102	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:46)

Disease	PMID	Source
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Renal cell carcinoma	18194544	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22581003	CNVD
Breast cancer	21990379	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:58 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:49295800-49309000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr11:49304800-49306200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
3	chr11:49305800-49306200	Enhancers	Fetal Brain Male	brain
4	chr11:49306200-49314400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr11:49307600-49309400	Enhancers	HUES6 Cell Line	embryonic stem cell
6	chr11:49307800-49309200	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr11:49307800-49309600	Enhancers	HUES48 Cell Line	embryonic stem cell
8	chr11:49308000-49309200	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr11:49308600-49309400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr11:49309000-49309600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr11:49309200-49313800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
12	chr11:49309600-49310000	Weak transcription	HUES48 Cell Line	embryonic stem cell
13	chr11:49310000-49310200	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr11:49310200-49313800	Weak transcription	HUES48 Cell Line	embryonic stem cell
15	chr11:49313800-49314200	Enhancers	iPS-20b Cell Line	embryonic stem cell
16	chr11:49313800-49314600	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr11:49313800-49314800	Enhancers	ES-I3 Cell Line	embryonic stem cell
18	chr11:49314000-49314800	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr11:49314400-49314800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr11:49319400-49319600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
21	chr11:49319800-49320400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr11:49320000-49320800	Enhancers	HUES48 Cell Line	embryonic stem cell
23	chr11:49320000-49320800	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr11:49320200-49320400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
25	chr11:49320200-49320600	Enhancers	ES-I3 Cell Line	embryonic stem cell
26	chr11:49320400-49320600	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr11:49320400-49320600	Enhancers	iPS-18 Cell Line	embryonic stem cell
28	chr11:49320600-49322000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
29	chr11:49320600-49322200	Weak transcription	HUES6 Cell Line	embryonic stem cell
30	chr11:49320600-49322400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
31	chr11:49320800-49321800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
32	chr11:49322000-49322200	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr11:49322000-49322800	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr11:49322200-49322800	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr11:49322400-49322800	Enhancers	ES-I3 Cell Line	embryonic stem cell
36	chr11:49322400-49322800	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr11:49322800-49324600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
38	chr11:49324600-49325000	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr11:49340000-49340400	Enhancers	ES-I3 Cell Line	embryonic stem cell
40	chr11:49341400-49342200	Enhancers	Liver	Liver
41	chr11:49347600-49348600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr11:49347600-49348600	Enhancers	iPS-20b Cell Line	embryonic stem cell
43	chr11:49347800-49349400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr11:49347800-49350400	Enhancers	HUVEC	blood vessel
45	chr11:49348000-49348600	Enhancers	HUES64 Cell Line	embryonic stem cell
46	chr11:49348000-49349400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr11:49348200-49348600	Enhancers	HUES6 Cell Line	embryonic stem cell
48	chr11:49348200-49350200	Enhancers	Ovary	ovary
49	chr11:49348400-49348800	Enhancers	HUES48 Cell Line	embryonic stem cell
50	chr11:49348400-49348800	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links